Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Carelabs Co., Ltd. (263700:KRX), powered by AI.
Carelabs Co., Ltd. is currently trading at ₩1,942. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Carelabs Co., Ltd. on Alpha Lenz.
Carelabs Co., Ltd.'s P/E ratio is 2.0.
“Carelabs Co., Ltd. trades at a P/E of 2.0 (undervalued) with strong ROE of 32.8%.”
Ask for details →Carelabs Co., Ltd. is a prominent player within the healthcare technology sector, specializing in developing digital solutions aimed at enhancing medical service delivery and patient care. As a company, Carelabs focuses on integrating technological advancements with healthcare services, providing software platforms and applications that streamline medical data management and patient interactions. It serves clients ranging from individual healthcare providers to large medical institutions, offering tools that improve efficiency and service quality. Carelabs's innovative approach positions it as a significant contributor to the ongoing digital transformation in the healthcare industry. This allows for more seamless healthcare experiences, making patient information more accessible and communication more efficient between healthcare providers and patients.
“Carelabs Co., Ltd. trades at a P/E of 2.0 (undervalued) with strong ROE of 32.8%.”
Ask for details →Carelabs Co., Ltd. (ticker: 263700) is a company listed on KRX in the Healthcare sector (Health Information Services). It has approximately 94 employees. Market cap is $37.7B.
The current price is ₩1,942 with a P/E ratio of 1.97x and P/B of 0.55x.
ROE is 32.80% and operating margin is -3.52%. Annual revenue is $81.7B.